Patents by Inventor Filippo Randazzo
Filippo Randazzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Process for depolymerizing plastic material for the production of hydrocarbons, and a plant therefor
Patent number: 11525090Abstract: A process for the depolymerization of waste plastic material and a reactor suitable for the depolymerization of waste plastic materials in said process.Type: GrantFiled: October 23, 2019Date of Patent: December 13, 2022Assignee: PROIL S.R.L.Inventors: Filippo Randazzo, Antonio Naviglio -
Publication number: 20210388271Abstract: The present invention relates to a process for the depolymerization of waste plastic material and a reactor suitable for the depolymerization of waste plastic materials in said process.Type: ApplicationFiled: October 23, 2019Publication date: December 16, 2021Inventors: Filippo RANDAZZO, Antonio NAVIGLIO
-
Publication number: 20120308569Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.Type: ApplicationFiled: June 7, 2012Publication date: December 6, 2012Applicant: NOVARTIS VACCINES & DIAGNOSTICS, INC.Inventors: Vivien W. CHAN, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
-
Patent number: 8221983Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.Type: GrantFiled: March 16, 2010Date of Patent: July 17, 2012Assignee: Novartis Vaccines and Diagnostics, Inc.Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
-
Publication number: 20100233187Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.Type: ApplicationFiled: March 16, 2010Publication date: September 16, 2010Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
-
Patent number: 7700359Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.Type: GrantFiled: September 22, 2004Date of Patent: April 20, 2010Assignee: Novartis Vaccines and Diagnostics, Inc.Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
-
Publication number: 20090036321Abstract: The present invention relates to methods of predicting the course of malignant disease and more specifically to methods which use SERPINE2 as a prognostic indicator of disease in cancer patients.Type: ApplicationFiled: June 3, 2004Publication date: February 5, 2009Applicant: Chiron CorporationInventors: Edward Moler, Filippo Randazzo, Michael Rowe
-
Publication number: 20070243176Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.Type: ApplicationFiled: July 7, 2003Publication date: October 18, 2007Inventors: Jaime Escobedo, Pablo Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Filippo Randazzo, George Lamson, Elizabeth Scott, Guozhong Zhang, Altaf Kassam, David Pot, Radoje Drmanac, Ivan Labat, Birgit Stache-Crain
-
Publication number: 20070010469Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.Type: ApplicationFiled: September 22, 2004Publication date: January 11, 2007Inventors: Vivien Chan, Jaime Escobedo, Pablo Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia Kennedy, George Lamson, Edward Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
-
Patent number: 7122373Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.Type: GrantFiled: May 13, 1999Date of Patent: October 17, 2006Assignee: Nuvelo, Inc.Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Klaus Giese, Filippo Randazzo, Giulia C. Kennedy, David Pot, Altaf Kassam, George Lamson, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, Lee William Jones, Birgit Stache-Crain
-
Patent number: 6964868Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.Type: GrantFiled: January 28, 1999Date of Patent: November 15, 2005Assignee: Nuvelo, Inc.Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Klaus Giese, Filippo Randazzo, Giulia C. Kennedy, David Pot, Altaf Kassam, George Lamson, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, Lee William Jones, Birgit Stache-Crain
-
Publication number: 20050227917Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.Type: ApplicationFiled: February 12, 2004Publication date: October 13, 2005Inventors: Lewis Williams, Jaime Escobedo, Michael Innis, Pablo Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Klaus Giese, Filippo Randazzo, Giulia Kennedy, David Pot, Altaf Kassam, George Lamson, Zhijun He, Elizabeth Scott, Guozhong Zhang, Theresa May, Doreen Sakamoto, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, Lee Jones, Birgit Stache-Crain
-
Publication number: 20040086913Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.Type: ApplicationFiled: June 26, 2003Publication date: May 6, 2004Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth Klinger, Christoph Reinhard, Zhijun He, Filippo Randazzo, Giulia C. Kennedy, David Pot, Altaf Kassam, George Lamson, Radjoe Drmanac, Mark Dickson, Ivan Labat, Lee William Jones, Birgit Stache-Crain
-
Publication number: 20030065156Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polymucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.Type: ApplicationFiled: February 15, 2002Publication date: April 3, 2003Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Klause Giese, Filippo Randazzo, Giulia C. Kennedy, David Pot, Atlaf Kassam, George Lamson, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, Lee William Jones, Birgit Stache-Crain
-
Publication number: 20030044783Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.Type: ApplicationFiled: March 9, 2001Publication date: March 6, 2003Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Filippo Randazzo, Giulia C. Kennedy, David Pot, Altaf Kassam, George Lamson, Radjoe Drmanac, Mark Dickson, Ivan Labat, Lee William Jones, Birgit Stache-Crain
-
Publication number: 20030023996Abstract: Human fat gene (hfat-2), and the amino acid sequence encoded by the hfat-2 gene are disclosed. hfat-2 is expressed at higher levels in normal prostate cells and in benign prostate cancer cell lines than in metastatic prostate cancer cell lines and tissue.Type: ApplicationFiled: July 21, 1999Publication date: January 30, 2003Inventors: Filippo Randazzo, David Duhl, Gary J. Miller
-
Publication number: 20020156035Abstract: Modulators of NET-4 are provided that reduce the expression or biological activities of NET-4 or the expression of NET-4 mRNA in a mammalian cell. NET-4 modulators include antisense molecules, ribozymes, antibodies and antibody fragments, proteins and polypeptides as well as small molecules. NET-4 modulators find use in compositions and methods for decreasing NET-4 gene expression as well as methods for inhibiting the proliferation of mammalian cells, including tumor cells, and methods for treating neoplastic diseases.Type: ApplicationFiled: June 5, 2001Publication date: October 24, 2002Inventors: Christoph Reinhard, Anne B. Jefferson, Jill A. Winter, Filippo Randazzo
-
Publication number: 20020076735Abstract: The invention provides materials and methods for determining the metastatic potential of a cell and for identifying cancerous cells by determining the presence or absence of one or more expression products of at least one gene that is differentially expressed between normal cells, nonmetastatic cells, cells of low metastatic potential, and cells of high metastatic potential.Type: ApplicationFiled: May 10, 2001Publication date: June 20, 2002Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Klaus Giese, Filippo Randazzo, Giulia C. Kennedy, David Pot, Altaf Kassam, George Lamson, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, Lee William Jones, Birgit Stache-Crain
-
Patent number: 6140483Abstract: A human tumor suppressor gene termed polyhomeotic 2 and its expression products can be used as therapeutic, prognostic, and diagnostic tools for proliferative and developmental disorders. Nucleotide sequences of the gene can also be used to identify a p34.3 region of a human chromosome 1.Type: GrantFiled: November 19, 1997Date of Patent: October 31, 2000Assignee: Chiron CorporationInventor: Filippo Randazzo
-
Patent number: 5914266Abstract: Mammalian Scm gene and amino acid sequences encoded by the mammalian Scm gene, are described. The mammalian Scm gene and gene products are useful for diagnostic and therapeutic applications in proliferative and developmental disorders. Modulators of mammalian Scm can be identified using the dislcosed genes. The modulators can be used in the context of cancer therapy or a treatment of a developmental disorder. Scm is also useful for inducing differentiation in a population of progenitor cells.Type: GrantFiled: May 6, 1997Date of Patent: June 22, 1999Assignee: Chiron CorporationInventor: Filippo Randazzo
-
Patent number: 5167485Abstract: A joint connection for abutting, circumferentially extending segments in a gas turbine engine, such as turbine nozzle segments, includes a sealing member which is insertable between longitudinally extending slots formed in the abutting side edges of two adjacent segments. The segments are each formed with a number of grooves which are longitudinally spaced along the length of the slots therein, and which extend beneath the sealing member carried within the slots. A cooling air flow path is thus formed extending from one side of the sealing member, into the longitudinal slot of each segment and then through the grooves to the opposite side of the sealing member so that the entire joint connection or seal region between the abutting side edges of the segments is cooled.Type: GrantFiled: April 6, 1992Date of Patent: December 1, 1992Assignee: General Electric CompanyInventor: John H. Starkweather